In The News

The significant costs of developing new, life-saving drugs and treatments has reached over $1.7 billion per drug over a span of 10-12 years, due to the growing complexity of drugs, bureaucratic red tape and the short length of a drug’s patent life.

It’s good news that there appears to be an agreement among Senate leaders for Congress to pursue fast track trade promotion authority, which would revitalize trade negotiations such as the Trans Pacific Partnership (TPP) and other agreements.

Updating ECPA for the Internet Age would allow Congress to show that it is sensitive to Americans’ privacy concerns and to reaffirm our Fourth Amendment protections. 

The question isn’t which countries receive U.S. foreign aid, but which ones DON’T get it?

If the cost of creating new drugs is high, the cost of not having any new drugs is immeasurable.

The Jewish vote goes overwhelmingly to Democratic candidates. But could President Obama’s deal with Iran erode that grip? And would it make any difference in the next presidential election?

Looking at the long list of IRS abuses, something needs to be done.

As venues and ticketing companies attempt to monopolize secondary ticket markets, now is the time for governments to address this issue and act to protect consumers' rights.

The U.S. has gone from asking "Where can we get more oil?" to "Where can we put it?" The US can ease the storage crunch and leverage the energy boom to the benefit of the U.S. economy by lifting the export ban on oil and natural gas.

At the end of the 113th Congress, lawmakers kicked the proverbial can down the road when they left the issue of taxing internet access to the 114th Congress.  Will 2015 be the year something changes?